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The American University in Cairo

ABSTRACT
Induced Pluripotent Stem Cells Derived From Mouse Germ Cells
By: Nora Khan
Under the supervision of: Dr. Asma Amleh
While embryonic stem cells are well known to give rise to tissues comprising all three
germ layers, only recently was it found that embryonic-like stem cells could be
derived from the postnatal mice testis in culture. Embryonic-like stem cells from
postnatal testes have shown that they can undertake most if not all, the functions of
embryonic stem cells. Most recent reports have demonstrated that somatic cells can be
induced to pluripotent stem cells, mostly with the addition of genes. However, the aim
of this work is to explore the potential of testicular cells to become pluripotent,
including expression of pluripotency-associated genes, and embryonic stem cells
morphology, without the addition of genes.
To accomplish our aim, we have sacrificed 15 CD-1 Swiss albino mice (8-10 weeks)
and harvested cells from the testes using both mechanical and enzymatic digestion
technique to generate single cell suspension. Isolated cells from the testes at day 1
along with embryonic-like stem cells at day 14 have been characterized via Reverse
Transcription - Polymerase Chain Reaction (RT-PCR) using germ cells marker
VASA, embryonic stem cells markers Nanog, cripto TDGF1, Esg1, and Thy1.
Furthermore, Immunophenotyping was performed via Flow Cytometer using
embryonic-like stem cells marker SOX2, CD 90 (Thy1), CD15 (SSEA-1), CD117 (ckit), and CD133.
Our results showed success in culturing cells harvested from the testes, these cells
were reprogrammed and had the characteristics of embryonic stem cell. RT-PCR
results confirmed the expression of VASA gene at day 1; these cells did not express
embryonic stem cells markers (Nanog, cripto TDGF1, Esg1, and Thy1). However,
embryonic-like stem cells at day 14 showed the expression of the previously
mentioned embryonic stem cells markers, and did not express Vasa, which is a germ
cell marker. Immunophenotyping results showed a noticed elevation in embryonic
stem cells markers (SOX2, CD 90, CD15, CD117, and CD133) at day 14 compared to
those at day 1.
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Here we report that embryonic-like stem cells can be derived from postnatal mice
testis. However, further studies are required to assure the optimum value of
embryonic-like stem cells that is dedifferentiated from mice testis before being used
clinically in human.
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1. Literature Review
1.1. What are Stem Cells?
Stem cells are considered primal cells, progenitors to 200 different cell types,
which is present in the adult body. Stem cells are characterized of self renewal and
unlimited potency; they have the ability to go through cycles of cell division while
remaining undifferentiated or differentiating into any mature cell type. As a result
stem cells are divided into four different types according to their potency; totipotent,
pluripotent, multipotent and unipotent (Murrell et al., 2005). During cell
development they become progressively differentiated in order to fulfill a specialized
function as a somatic cell. Totipotent stem cells are the cells produced from the first
few division of a fertilized egg. All embryonic and extraembryonic tissue can only
rise from zygotes and blastomeres of early morulas. In this stage the cells present are
called “totipotent”. Morula cells are totipotent which are able to differentiate into any
tissue including placental tissues. Cells residing in the inner cells mass can only give
rise to embryonic tissues but not to extraembryonic ones, and these cells are called
“pluripotent”. Pluripotent stem cells are able to differentiate into the 3 germ layers.
Moreover, cells in the adult tissues such as adult stem cells are called “multipotent”
giving rise to cells of closely related family such as hematopoietic stem cells which
differentiate into white blood cells, platelets, red blood cells, etc. Multipotent stem
cells also referred as adult stem cells are considered as a repair system for the body,
which can replace damaged cells. Last, there is the “unipotent” which are stem cells
than can give rise to one cell lineage, but they still have the property of self-renewal
which differs them from other non stem cells such as spermatogenic stem cells
(Avasthi et al., 2008).
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1.2. Types of Stem Cells
Stem cells are classified into categories: embryonic stem cells and adult stem cells.

1.2.1. Embryonic Stem Cells
Embryonic stem cells are present at embryo’s developmental stage, this
developmental stage is known as the blastocyst stage, pluripotent stem cells can be
derived from such stage. From embryonic stem cells all 3 germ layers can rise:
mesoderm, endoderm, and ectoderm (Niwa et al., 2000). Embryonic stem cells can be
maintained in culture and can develop into more than 220 cell types of adult
differentiated cells when certain growth factors and stimulation is maintained in the
culture. Besides, maintaining of pluripotency of embryonic stem cells has been
established in vitro by adding the culture media specific for embryonic stem cells
growth (Caveleri et al., 2003). The factors that maintain the pluripotency of
embryonic stem cells is regulated with the aid of transcription factors. Such
transcription factor is important for the cells to keep its identity, regulate its
development from the primitive stage to a functional differentiated cell. There are a
number of proteins, which were discovered, that regulate embryonic stem cells’
pluripotency. Some of these proteins are Nanog, Oct4, Klf4, and Sox2 (Wang et al.,
2007). The indefinite ability of embryonic stem cells of self-renewal along with their
plasticity allowed in vitro generation of different distinct cell types.
A lot of research has been dedicated to use the characteristics of embryonic
stem cells and their self-renewal properties in regenerative medicine. One of the main
aims of researches done in the field of embryonic stem cells is to generate specialized
cells from embryonic stem cells, which can be used in replacing damaged tissues in
patients that suffer from different degenerative diseases. Moreover, to accomplish
success of embryonic stem cells based therapies; the appropriate culture conditions
must be studied and developed to produce genetically stable cells to avoid adverse
effects which might follow transplantation such as the formation of tumors that is
caused from the rapid growth of embryonic stem cells when grown in adult patients.
(Vazin et al., 2010).
2	
  
	
  

	
   	
  

1.2.2. Adult Stem Cells
Adults’ stem cells are considered undifferentiated cells and are also called
somatic stem cells, it is found in children and adults. To ensure self-renewal, adult
stem cells undergo two types of cell division: asymmetric division giving rise to a
daughter stem cells and a progenitor cell, and symmetric division giving rise to two
daughter stem cells. Progenitor cells are the type of cells, which differentiate into
mature cells. Regulating the differentiation of adult stem cells has been studied
revealing the molecular mechanism, which control their self-renewal and
differentiation including; Bmi-1, Notch, and Wnt signaling (Molofsky et al., 2003).
First, Bmi-1, which is a transcription repression factor, it was shown to have a role in
regulating hematopoietic stem cells and neural stem cells (Park et al., 2003). Second,
the Notch pathways, which have an important role in cell-to-cell communication, this
involves gene regulation mechanisms which control differentiation process of stem
cells. Besides, the Wnt signaling pathway which has a role in embryonic development
including cell fate specification, cell proliferation and cell migration (Beachy et al.,
2003).

There are different types of adult stem cells, hematopoietic stem cells are one
of these types, and it is present in the bone marrow, cord blood and peripheral blood
(Verfaillie, 2002). Hematopoietic stem cells are the early precursor cells which
differentiate to all blood cell types. Hematopoietic stem cells have the ability to
reconstitute the bone after any depletion, which might be caused by a disease (Orkin
et al., 2002). The bone marrow is also rich with stromal stem cells; also know as
mesenchymal stem cells. Mesenchymal stem cells have the ability to differentiate
into different cell types including chondrocytes, myocytes, adipocytes, and osteoblast
(Zuk et al., 2002). Moreover, there are neural stem cells, which is present in the adult
brain. It was discovered with the discovery of neurogenesis; the birth of new neurons.
Although the process of neurogenesis has been well established, the presence of true
self-renewing stem cells in the hippocampus is still debatable (Bull et al., 2005).
There is also the Olfactory adult stem cells which is harvested from the olfactory
mucosa cells; the lining of the nose. Another type of adult stem cells is the adipose
	
  

3	
  

derived adult stem cells; they can be isolated from fat tissues. Adipose derived stem
cells have shown their ability to differentiate to bone, fat, and muscle tissues, and they
are relatively similar to mesenchymal stem cells collected from the bone marrow
(Zuk et al., 2002).
1.3. Characteristics of Embryonic Stem Cells
Embryonic stem cells grow in colonies that are tightly packed together, with a
defined border at the periphery of each colony. Besides, embryonic stem cells are
characterized with a high nucleus to cytoplasm ratio. On the molecular level,
embryonic stem cells express a number of cell surface markers and transcription
factors such as Oct3/4, TRA antigens, SSEA4, and Nanog (Carpenter et al., 2003).
Moreover, embryonic stem cells have the ability to differentiate into all three germ
layers in vivo and in vitro(Reubinoff et al., 2000).
1.3.1. Embryonic Stem Cells Markers
Embryonic stem cells markers are considered to be molecules that are
specifically expressed in the embryonic stem cells. It is critical to understand the
function of these markers for characterizing embryonic stem cells and studying their
mechanism of maintenance and self-renewal. This is difficult in some cases as
embryonic stem cells might share single or multiple markers with other types of cells.
The marker based flow cytometry technique along with the magnetic cell sorting are
being used to initially identify and isolate embryonic stem cells (Zhao et al., 2012).
There are many molecules that are identified to affect the self-renewal and
pluripotency of embryonic stem cells. Recent studies have discovered a wide range of
cell surface markers such as proteins that might be involved in a number of signal
pathways that can control cell fate decision (Prowse et al., 2007). Some of these
embryonic stem cells surface marker are:
•

Stage Specific Embryonic Antigens (SSEA):
They were identified by 3 monoclonal antibodies recognizing carbohydrate

epitopes present with the globo- and lacto- series glycolipids. These carbohydrateassociated molecules were found to be involved in controlling cell surface interaction
that is during development (Shamblott et al., 1998). SSEA1, which is also, know as
CD15 are expressed on the surface of murine embryo pre-implantation. It was also
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found on the surface of human germ cells but not in human embryonic stem cells. As
a result expression of SSEA1 increases in differentiated human cells, and decreases in
differentiated murine cells (Draper et al., 2002; Henderson et al., 2002).

•

Cluster of Differentiation (CD) antigens:
They are surface proteins that belong to different class such as glycoproteins,

receptors, integrins, and adhesion molecules. There are different CD antigens that
identify different types of cells, CD antigens are recognized by antibodies and are
used as an efficient tool in cell sorting and cell characterization. CD antigens
associated with embryonic stem cells are CD9, CD24, CD133, CD90, and CD117;
these markers were found to be expressed in both human and murine embryonic stem
cells (Sundberg et al., 2009).
•

Cripto TDGF1:
This gene encodes a growth factor, which is structurally related to epidermal

growth factor. Cripto act as a co receptor for transforming growth factor β (TGF-β)
ligands, and it has a critical role during embryogenesis. Studies showed that Cripto
TDGF1 is expressed in tumors and they have a role in promoting tumourigenesis
(Gray et al., 2006).
•

Transcription Factors:
Transcription factors have an important role in gene regulation, tracking the

expression of these genes can be used as a marker for certain types of cells. The work
of Yamanaka revealed that it is possible to induce pluripotency to mouse embryonic
fibroblast by the introduction of four factors: Oct4, Sox2, Klf4 and c-Myc
(Yamanaka et al., 2006).
o Octamer-binding Proten 4 (Oct4)
Oct4 is a member of the POU transcription factors family; it plays a crucial
role in regulating stem cell pluripotency. Oct4 expression is restricted to embryonic
stem cells and germ line cells, their expression is maintained in the inner cell mass.
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Moreover, Oct4 control the expression of other genes such as Sox2, Fgf4, Rex1and
Utf1, along with the repression of the gene encoding hCG (human embryonic
gonadotropin) (Pan et al., 2002).

o Sry-related High-mobility Group (HMG) Box-containing (Sox)
Family
The Sox family is HMG box transcription factor; they interact functionally
with POU domain. Sox2 and Oct3/4 are involved in maintaining pluripotency,
however Oct3/4 is exclusively expressed in embryonic stem cells, and Sox2 is
expressed in pluripotent, multipotent and unipotent stem cells (Boyer et al., 2005).
Sox2 is one of the important genes that were initially used for induction of induced
pluripotent stem cells. Sox2 is expressed in both mouse and human embryonic stem
cells, and pre-implantation embryos. Besides, sox2 is expressed with Oct4 in post
migratory primordial germ cells (Yamanaka et al., 2006; Yu et al., 2007).
o Krupple-like Factor (Klf) Family
The Klf family is involved in different biological processes, which includes
proliferation, differentiation, apoptosis and development. The three Cys2 His2 zinc
fingers, which are located at the C terminus, characterize the Klf family and it is
separated by a highly conserved H/C link. Klf5 regulates the transcription of both
Nanog and Oct3/4, it is involved in embryonic stem cells renewal and maintaining
pluripotency (Ghaleb et al., 2005). Klf2 and Klf4 are also involved in maintaining
self renewal and pluripotency, besides they regulate the expression of other
embryonic stem cells transcription factors such as Nanog, Sall4, and Mycn. Studies
showed that Klfs family members alone are not important for embryonic stem cells
self-renewal (Jiang et al., 2008; Parisi et al., 2008).
o Nanog
Nanog is one of the important transcription factors that play a crucial role in
maintaining pluripotency in both mouse and human embryonic stem cells. Their
expression in human embryonic stem cells is much lower than their expression in
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mouse embryonic stem cells (Hatano et al., 2005). The expression of Nanog is
downregulated early during embryonic stem cells differentiation; this explains the
restricted expression of Nanog in embryonic stem cells and their role in maintaining
pluripotency. Studies showed that Nanog deficient inner cell mass failed to generate
epiblasts, and results showed that it was able to produce only endoderm like cells
(Mitsui et al., 2003). Molecular results showed that Nanog mRNA is present in
embryonic stem cells, not present in differentiated cells, but present in founder cells
from which embryonic stem cells is derived in preimplantation embryos (Chamber et
al., 2003).
o Developmental Pluripotency-associated (DPPA) Genes
DPPA family consists of 5 proteins, which are related by names only, besides
they are Oct4 related genes. They are markers for both early embryonic and germline
pluripotent stem cells (Tanaka et al., 2006). DPPA5, which is also known as ESG1,
is expressed in embryonic stem cells (Western et al., 2005). Moreover, DPPA3 also
called “Stella” is expressed in oocytes, preimplantation embryos, embryonic stem
cells, and primordial germ cells (Du et al., 2010). DPPA4 was found to regulate the
differentiation of embryonic stem cells to primitive ectoderm lineage (MaldonadoSaldivia et al., 2007).
1.4. Ethical Concerns in Embryonic Stem Cells Research
Embryonic stem cells are derived from the inner cell mass of the blastocysts.
The blastocyst is formed after 5 days of fertilization. The isolation of embryonic stem
cells from the inner cell mass causes destruction of the embryo, as a result a lot of
ethical concerns are against using embryonic stem cells in research. One of the major
sources of human embryonic stem cells is the spare embryo, which is created for in
vitro fertilization for infertility treatment. Another source is creating an embryo by
somatic cell nuclear transfer techniques, only to isolate embryonic stem cells from
them. Some countries allow the use of the spare embryos as a source for embryonic
stem cells such as India. Other liberal countries allow the creation of embryos to be
used as a source for embryonic stem cells. The issue of embryonic stem cells and their
use in research is still controversial, some people and governments are with and
others are strictly against (Caulfield et al., 2014).

	
  

7	
  

As mentioned previously, the extraction of embryonic stem cells involves
destruction of an embryo. Two opposing opinions are raised against using embryonic
stem cells; one side emphasis on the importance of using embryonic stem cells and
their potential in stopping the pain of a patient, and the other side stresses on the value
of human life. People see that embryonic stem cells can provide a treatment for
serious diseases, and using a spare frozen embryo might save a life of another person.
On the contrary, other people might see that destructing an embryo is against ethics as
human’s life is of a value that no one should control (Weise, 2013; Doerflinger,
1999).
1.5. Somatic Cell Nuclear Transfer
Briggs and King established the somatic cell nuclear transfer technique to
study the potential of transplanting an isolated nucleus from late-stage embryos into
enucleated oocytes (Briggs et al., 1955). At the beginning scientists have been using
this technique as a tool to study the developmental potential of a cell. The idea of this
technique was to remove the nucleus of a recipient egg by a glass needle, the cell
content of a donor cell is then transferred to the enucleated egg (Briggs and Kind,
1952). These finding helped the development of Dolly the sheep and other mammals
from an adult cell (Wilmut et al., 1997). Their results showed that it is possible that
the genome of a fully differentiated cell to remain genetically totipotent (Gurdon et
al., 2003; Hochedlinger et al., 2006).
1.6. Induced Pluripotent Stem Cells (iPSCs)
Induced pluripotency discovery is built on the following; (1) the
development of techniques which gives the chance to scientists to isolate, culture and
study pluripotent stem cells, (2) studying the effect of transcription factors in
determining the fate of a cell, these transcription factors’ enforced expression can
change the fate of one mature cell type into another one, and (3) the technology of
somatic cell nuclear transfer (Stadtfeld et al., 2012). The work of Yamanaka and
Takahashi in 2006 made a great breakthrough in the field of iPS. Their work showed
that when certain transcription factor are introduced to somatic cells, this cell could be
reprogrammed to an embryonic-like state. Yamanaka’s experiment involved
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screening and identifying 24 pluripotency associated genes that might be used in
cell’s reprogramming. Their results showed that 4 specific genes could reprogram a
somatic cell; these genes were Klf4, Sox2, c-Myc, and Oct4. After introducing those 4
genes, the resulting iPS cells showed morphological and molecular features indicating
that they are embryonic-like. Besides, these cells generated teratomas in
immunocompromised mice, and they had the ability to differentiate into the three cell
lineages. (Yamanaka et al., 2006). Nevertheless, results revealed that the level of
pluripotency in iPS cells is markedly lower than that of embryonic stem cells.

Using Viral Vectors in iPS
There are several means to dedifferentiate somatic cells to pluripotent cells;
induction can be done by using viral vectors, or with no viral vectors by using
chemical treatment for the cells. There are advantages and disadvantages for each
method. A considerable amount of work has been carried out in the field of inducing
pluripotency using viral vectors. The area of using viral vectors in iPS can be
subcategorized to 3 different methods; the use of lentiviruses, the use of retroviruses,
and the use of nonintegrating viruses (O’Doherty et al., 2013). Takahashi and
Yamanaka’s work described the use of retroviruses in producing the first iPS; the
used retrovirus was stably integrated into the host genome (Yamanaka et al., 2006).
From the drawbacks of this technique is the activation of methyltransferases, this
meant that the corresponding endogenous genes were not activated and the
reprogramming is incomplete. Besides, the viral transgenes, which was integrated into
the genome of iPS cells, might cause the formation of tumor in chimeric animals
(Okita et al., 2007). The use of retroviruses in inducing pluripotency has given a
highly efficient iPS cells, nevertheless, the risk of tumor formation is an obstacle in
using iPS cells in clinical settings. A lot of studies have been done in the field of iPS
in order to over come the issue of tumor formation. Nagawaka et al. have generated
chimeric mice that survived till day 100 using iPS cells; they have done that without
using Myc as a factor (Nakagawa et al., 2008). Results revealed that c-Myc was
found to increase tumor formation when used in reprogramming. However, some
research was done showing that when using L-Myc,which is a different Myc family
member, reprogramming was promoted with the risk of tumor formation (Nakagawa
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et al., 2010). Another method that is used in reprogramming is by using lentiviral
vectors; it is considered a controlled method of reprogramming. This control is done
by the drug doxycycline that decreases the risk of transgene expression, allowing only
the selection of fully reprogrammed cells (Stadtfeld et al., 2008).
1.6.1. Nonviral method for iPS
Results revealed that viral methods of reprogramming are highly efficient,
nevertheless they were proven to be too risky in order to be used clinically. There are
various methods that have been put forward in order to overcome the risk of using
viral methods in reprogramming. One of these methods is transfection of mouse
fibroblast by two expression plasmids; one plasmid contained cDNA of Oct3/4, Klf4,
and Sox2, the other plasmid contained c-Myc. This method showed high
reprogramming efficiency without the risk of using viral vectors and their integration
into the host DNA. This technique showed high efficiency which was desirable, they
proved to be too risky to be used in a clinical setting owing to their insertional
tendencies. The necessity to find an iPS method that could be used in the clinic was
then sought after. Various strategies for nonviral reprogramming have been put
forward and will be discussed in the following section (Okita et al., 2008). Another
Nonviral method is using episomal vectors for reprogramming of somatic cells to
embryonic-like stem cells. In this method fibroblasts is transfected with an episomal
with Epstein- Barr nuclear antigen-1 which is derived from the Epstein Barr virus.
This vector was chosen because it can be used in transfection with using viral
pachaging, moreover it can be removed from cells by a drug selection method
(Junying et al., 2009). One of the alternative methods for reprogramming is the use
of small molecules and chemical compounds. The main aim of this method is to
substitute the use of viral vectors with a cocktail of chemicals or molecules, which are
used to enhance the process of reprogramming. Results revealed that this method
could efficiently produce stable iPS free of mutation and integration. This method is
considered to be safe as it depends on influencing pathways instead of relying on
genetic modification for cell reprogramming (Lin and Wu, 2015). Nevertheless,
using chemicals instead of transcription factors in reprogramming results in a
decreased number of iPS clones, which result in a less yield (Shi et al., 2008).
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1.7. Derivation of iPSCs from postnatal testis
Germ cells are unique type of cells as they have the ability to transmit the
genome from a generation to another. A number of researches emphasize on the
relationship between embryonic stem cells and early germ cells, as they state that is
because of naturally occurring pluripotency of embryonic stem cells and the
totipotency property of germ cells (Zwaka et al., 2005).

A number of researches have been dedicated to the use of cells collected from the
testis in iPSCs research. Reports have shown that spermatogonial stem cells can be
transformed by an unknown mechanism in vitro into embryonic like stem cells
without the use of any viral vectors. This embryonic like stem cells showed similar
characteristics and expression profile when put in the appropriate culture conditions to
embryonic stem cells (Skutella and Conrad, 2011). This method overcame the
ethical concern of using embryonic stem cells and the drawback of using viral vectors
in induction of pluripotency. The past few years have shown that pluripotent stem
cells derived from adult testis has a great implication in the field of regenerative
medicine (De Rooij, 2006). Even though these cells are unipotent, it was found that
when they are put in certain conditions they give rise to cells that are pluripotent
(Guan et al., 2006). A lot of studies have reported that it was successful to generate
embryonic like stem cells from spermatogonial stem cells, these cells were able to
generate teratomas in immunodeficient mice, they showed similar expression profiles
to embryonic stem cells, and they are able to differentiate into all germ layers in vitro
(Kanatsu-Shinohara et al., 2004).
1.8. Application of iPSCs
One of the main difficulties in treating many diseases is the lack of
information about the mechanisms, which causes disease progression. As a result,
disease modeling is important in order to develop treatments triggering the main
cause of the disease. iPSCs is used in disease modeling, as they have the ability to
function in vitro as well in vivo after transplantation. iPSCs are not only used in
disease modeling, they are also used in drug discovery, and regenerative medicine as
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well (Vimal et al., 2015).
The use of iPSCs in disease modeling is because of their self-renewing
capabilities along with the ability of these cells to differentiate into all types of cells in
the human body. Besides, using the patient’s iPSC could be of enormous importance
as in developing a patient specific therapeutic drug. These cells have been used to
study the mode of action and mechanism of different diseases such as studying the
mechanisms, which regulate the differentiation of urinary tract and prostate cells.
Their results revealed that iPSCs from the previously mentioned sources have better
efficiency in differentiation than iPSCs derived from skin fibroblast. These findings
indicate that the organ of origin has a role in the efficiency of differentiation of iPSCs.
Another important use of iPSCs is in drug discovery and cytotoxicity studies.
For these studies scientists either use animal models or in vitro animal derived cells.
However using iPSCs is of better potential as it gives the chance of using the exact
human cells giving better insight of the exact human physiological conditions and
their phenotypic attributions (Yoshida and Yamanaka, 2010). Besides, one of the
drawbacks of using animal models in drug toxicity is that some chemicals might be
toxic to animals and not to humans. As a result, it is important to test new drugs or
therapy on human cells to get efficient results. Development of drug testing models
before being used in clinical trials might reduce costs and safe lives. iPSCs can be
used to test drug toxicity and side effects. This is fulfilled because they provide a
similar environment to the human physiology (Seiler et al., 2004).
One of the important used of iPSCs is in regenerative medicine; it is used in
treating injured or degenerated tissues. iPSCs offer a good solution as the cells that is
being transplanted is generated from the patient’s own somatic cells. A number of
degenerative diseases and injuries can be treated by using iPSCs such as
musculoskeletal injuries, spinal cord injuries, liver damage, cardiac diseases, and
hematopoietic disorders (Liu et al., 2011b; Suzuki et al., 2013).
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1.9. Objectives and Experimental Plan
•

The main objective of this study is to establish embryonic-like
stem cells from adult mouse testis.

•

To achieve our goal, mouse testis was harvested and
enzymatically digested into single cell suspension cultured under
specific culture conditions that promote the development and
survival of pluripotent stem cells.

•

The established embryonic-like stem cells were characterized at
the molecular and histological levels.
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2. Materials and Methods
2.1. Isolation of germ cells from adult males testes
Most of the procedures performed as regard isolation, harvesting,
dedifferentiation of germ cells to embryonic like stem cells were done in reference to
the work of (Golestaneh et al., 2009). We obtained mouse testes from 15 adult male
CD-1 Swiss albino mice (8-10 weeks). Internationally valid guidelines were used in
all animal experiments that were carried out. Three independent experiments were
performed; each experiment utilized three mice. Mice were euthanized and dissected;
testes were isolated and placed in Dulbecco’s Modified Eagle Medium (DMEM,
GIBCO, USA). Testes were then washed in sterile Phosphate Buffered Saline (PBS)
(Lonza, Switzerland) in six well plates. In each experiment, mice testes (3 mice) were
collected and placed in 100mm cell culture dish (Corning, USA) with serum-free
DMEM. Testes were then decapsulated and enzymatic digestion was performed over
two steps; the first step was with collagenase IV (Worthington Biochemical Corp,
USA) with concentration of 1mg/mL, cells were incubated for 20 minutes in CO2
incubator (Shallab, USA) with temperature adjusted to 37 °C. Cells were then washed
with PBS and centrifuged at 300xg for 10 minutes at 15-20 °C. The second step of
digestion was done by adding hyaluronidase (Sigma), trypsin (GIBCO, USA), and
collagenase IV with concentration 1.5, 1.1 mg/mL respectively to the isolated
seminiferous tubules. The cells were again incubated at 37° C but for 20 minutes.
Adding serum-containing medium then inactivated trypsin; cells were again washed
by PBS and centrifuged at 300xg for 10 minutes. These steps were performed to
obtain individual cells for primary cell culture. 1 ml of the cell suspension is collected
to be used in molecular testing, pathology & cytology, and flow cytometry. This
sample is referred as sample collected at “Day 1”.
Before proceeding to culturing of cells collected from the testis cell count and
viability were performed by trypan blue exclusion staining. In order to perform viable
cell count test, 20 µl cells were added to 20 µl 0.4% trypan blue (Sigma, USA), cells
were counted using a hemocytometer (Hausser Scientific, USA).
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2.2. Dedifferentiation of germ cells to embryonic like stem cells.

Cells collected from the testis were cultured in six well plate dishes that were
gelatin coated. The seeding density of the cells was 200,000 cell/cm2. Preparation of
0.1% gelatin was done by adding 0.5 g gelatin powder to 500 ml endotoxin-free
water, and then the mixture was autoclave for 30 minutes. 0.1% gelatin was then left
to cool at room temperature. 2 ml of 0.1% gelatin was added to each well of six well
plates, gelatin is left in the wells for 1 hour. Gelatin is then discarded and the wells are
left for two hours to dry. For each well a mixture of germ cells with 15% knockout
serum replacement for ES cells (Gibco, USA), Knockout DMEM (Gibco, USA), 0.1
µM β-mercaptoethanol (β-ME, 10 mM, Serva, Germany), 1× penicillin–streptomycin
(Gibco, USA), 2 mM l-glutamine (Gibco), 100× nonessential amino acids (NEAA,
Gibco, USA), 10 ng/mL, recombinant mouse fibroblast growth factor basic (bFGF,
Gibco, USA), and 0.12 ng/mL recombinant mouse transforming growth factor β3
(TGF-β, Gibco, USA). After 5 days colonies of small embryonic like stem cells
started to be formed. After a week of culture, cells started reaching 80-90%
confluency; cells were trypsinized by trypsin/EDTA and they were cultured in new
six well gelatin coated plates. This was repeated weakly up to eight weeks. Media
were changed twice a week with the same mixture mentioned previously. Cells were
regularly examined by using inverted microscope (Olympus 1X70, USA) to monitor
and characterize their morphology.
2.3. Reverse Transcription- Polymerase Chain Reaction analysis

Molecular testing was performed at day 1 of cells collected from the testis and
at day 14, which is the end of the dedifferentiation cycle. Total RNA was extracted
from cell pellets at day 1 and day 14 using Trizol (Invitrogen, USA) as per
manufacturer’s protocol. RNA was dissolved in diethylpyrocarbonate (DEPC) water.
RNA was then qualified using Shimadzu spectrophotometer UV-1800 at A260mm.
Synthesis of cDNA was done from 1 µg RNA using RevertAID cDNA synthesis kit
(Fermentas, USA) as per manufacturer’s protocol. β actin was used as an internal
control. For each reaction mixture, 1 µl of cDNA was added to 1 µM of each mouse
specific reverse and forward primers. The used primers for molecular analysis were
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Vasa, Nanog, cripto TDGF1, Esg1, and Thy1. The reaction also contained 2 µl 10X
DreamTaq Buffer, 1 µl of 10 mM dNTP, and 1 U of DreamTaw DNA Polymerase
(Fermentas Inc, USA). To complete the reaction nuclease free water was added to
form a total mixture of 20 µl. Each primer had its primer specific cycle programs;
PCR machine used for this test was a Verti Thermal Cycler (Applied Biosystems,
USA). The sequences of each primer along with, their amplicon size, annealing
temperature, and number of PCR cycles required is mentioned in table 1. PCR
products were electrophoresed on 2% agarose gel. Ethidium bromide (Sigma, USA)
was added to the gel during preparation to visualize the bands. Each gel was
photographed under UV light using GelDoc (Biorad, USA). ImageJ software (NIH,
USA) was used in assessment of the bands.
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Table 1 Primers used in the study
	
  
Gene

Sequence

Amplicon

Annealing

No. of

Size

Temperature

PCR

Reference

cycles
Mouse

F-5’GGTCCAAAAGTGACATATATACCC3’

Vasa

420 bp

57°C

25

R-5’TTGGTTGATCAGTTCTCGAGT3’

Toyooka Y. et al.,
2000. Expression and
intracellular localization
of mouse Vasahomologue protein
during germ cell
development.

Mouse

F-5’GGCTGCCCTCTCCTCGCCCTT3’

Nanog

R-5’CCAAGGCTGGCCGTTCCAGG3’

583 bp

Mouse

F-5’ATGGACGCAACTGTGAACATGATGTTCGCA3’

cripto

R-5’CTTTGAGGTCCTGGTCCATCACGTGACCAT3’

174 bp

66°C

58°C

35

35

TDGF1

Mouse

F-5’GAAGTCTGGTTCCTTGGCAGGATG3’

Esg1

R-5’CTCGATACACTGGCCTAGC3’

Mouse

F-5’GCCGCCATGAGAATAACA3’

Thy1

R-5’GCCGCCATGAGAATAACA3’

Mouse

F-5’ACGCAGGATTTCCCTCTCAGC3’

B-actin

R-5’GGCCCAGAGCAAGAGAGGTAT3’
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376 bp

58°C

35

753 bp

60°C

45

460 bp

60°C

27

Takahashi K. and S.
Yamanaka. 2006.
Induction of pluripotent
stem cells from mouse
embryonic and adult
fibroblast cultures by
defined factors.

Takahashi K. and S.
Yamanaka. 2006.
Induction of pluripotent
stem cells from mouse
embryonic and adult
fibroblast cultures by
defined factors.

2.4. Immunophenotyping by Flow Cytometer
Aliquots were taken on day 1 after harvesting of cells from the testes, and on
day 14 of culturing cells collected from the testis. Cells from day 14 were collected
after trypsinization for 5 min at 37°C, cells were then recovered by centrifugation at
500xg for 5 mins. Cells were then washed with 2 ml phosphate buffer saline and
followed by vortex, and centrifugation step. For each reaction the specific antibody
was added and incubated fro 20 min in the dark at 4°C. Cells were washed again with
phosphate buffer saline, and analyzed on a COULTER Epics XL flowcytometer
(Beckman Coulter, Mexico) and data acquisition and analysis were performed using
XL System II software. A list of the cluster of differentiation surface markers used in
flowcytometer analysis is in table 2 along with the function of each.
Table 2 CD surface markers used in Flowcytometer analysis

CD Marker

Function

CD 90 (Thy1)

Mouse embryonic stem cells

CD 15 (SSEA-1)

Mouse embryonic stem cells
& Mouse germ cells

CD117 (c-kit)

Mouse embryonic stem cells
& Primordial germ cells

CD133

Mouse embryonic stem cells

SOX2
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2.5. Statistical Analysis

Data presented are collected from three independent experiments.
Comparisons were carried out using one-way analysis of variance (ANOVA).
Statistical analysis was performed and plotted using GraphPad Prism software version
5 (GraphPad Software, USA).
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3. Results
3.1. Cellular characterization of cells collected from the testis
The main objective was to derive embryonic-like stem cells from mice testis..
Mice were sacrificed in three independent experiments, and then the testis was both
mechanically agitated and enzymatically digested. Cells collected from the testis were
obtained devoid of connective tissue cells and interstitial components and cultured in
defined media designed for embryonic stem cells. The viable cell count of the cell
suspension was an average of 2 x106 in each culture plate, and the average rate of
viable cells was 91% suggesting that the majority of the recovered cells were viable.
It was critical to use a well-defined culture medium. This media is important for
optimal derivation and maintenance of cells isolated from the testes, and to maintain
the undifferentiated conditions and induce their reprogramming towards being
embryonic-like stem cells.
After culturing the testicular cells for 24 h, they started to adhere to the surface
of the culture plate. Using the inverted microscope to analyze the morphology of the
cells, they were seen round or oval in shape with a little cytoplasm and a large nucleus
as shown in figure 1. The cultured cells tended to form small colonies; each colony
was 3-5 cells.
A	
  

Figure 1 Cellular characterization of germ cells at day 1. Adherent cells at day 1
after harvesting of testicular, cells are all round shaped with different sizes of cells
indicating there are different cell types (x20). Round spermatids (arrow)
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3.2. Dedifferentiation of adult testicular cells into embryonic-like stem cells
At day 4, cells started to form packed colonies of embryonic-like stem cell;
these colonies became multilayered with clear boundaries appearing under the
inverted microscope. Colonies were successfully expanded and passaged to up to 8
passages. The phenotype of those grown embryonic-like stem cells at day 4-14
resembles those of mouse embryonic stem cell colonies (Figure 2). What was
significant to notice that these cells were very resistant to disaggregation by
trypsin/EDTA based reagent, and it took more time for their disaggregation during
subculture steps. It was noted that after day 14 the growth of embryonic like stem
cells colonies started to decrease to reach the least at day 50.

A	
  

B	
  

C	
  

F

Figure 2 Morphological examination of cultured embryonic-like stem cells.
(A)&(B) Showing a colony of embryonic-like stem cells (arrowheads)	
  at day 7
(x40). (C)	
  The	
  only	
  surviving	
  cell	
  type	
  is	
  the	
  embryonic-‐like	
  stem	
  cells	
  which	
  
formed	
  a	
  colony	
  (arrowheads)	
  (x20).	
  (D)	
  Colonies	
  of	
  embryonic-‐like	
  stem	
  cells	
  at	
  
day	
  14	
  showing	
  only	
  few	
  colonies	
  with	
  an	
  increase	
  in	
  the	
  number	
  of	
  colonies.	
  
	
  
	
  
	
  
G
	
  

	
  

21	
  

3.3. Expression patterns of cells collected from the testis at the RNA level
For further analysis of testicular cells at day 1, RT-PCR was performed to test
the expression of cells collected from the testis and embryonic stem cells markers.
As shown in figure 3 a high expression of VASA, a germ specific-marker, whereas
embryonic stem cells markers such as Nanog, ESG1, cripto TDGF1, and Thy1 were
not expressed at the RNA level from cells collected at day 1 (Figure 3, 4, 5, 6, 7).
VASA gene, which is strictly expressed in gonads, and undetectable in somatic cells,
is uses as a marker used for germ cells. VASA was not detected in embryonic-like
stem cells (ESC-like) (Toyooka et al., 2000).
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Figure 3 Expression of VASA surface marker in testicular cells and embryoniclike stem cells by RT-PCR. (A) Representative RT-PCR gel image for the loading
control β-actin (460 bp) and VASA (420 bp). gel 1 is for day 1 testicular cells and day
7 embryonic-like stem cells, gel 2 is for day 1 and day 14 embryonic-like stem cells,
and gel 3 is for the internal control(B) Bar chart representing normalized expression
of VASA relative to loading control. Data is collected from three independent
experiments.
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3.4. Expression patterns of embryonic stem cell markers at the RNA level
We examined the expression of a number of embryonic stem cells markers in
testicular cells and embryonic-like stem cells. As shown in figure 4 Nanog is strongly
expressed in embryonic-like stem cells and not expressed in the testis. Nanog is one
of the transcription factors, which have a role in pluripotency of the cell.
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Figure 4 Expression of Nanog surface marker in the testis and embryonic –like
stem cells by RT-PCR. (A) Representative RT-PCR gel image for the loading
control β-actin (460 bp) and Nanog (583 bp). gel 1 is for day 1 testis and day 7 ESClike, gel 2 is for day 1 and day 14 ESC-Like, and gel 3 is for the internal control (B)
Bar chart representing normalized expression of Nanog in relative to loading control.
Positive control is collected from spleen. Data is collected from three independent
experiments.

	
  

23	
  

One of the surface markers of embryonic stem cells is Thy1. Results revealed
that the expression pattern of Thy 1 is slightly higher in embryonic-like stem cells
than cells collected from the testis at day 1. Figure 5 reveals expression pattern of
Thy1 from testis and embryonic-like stem cells from three independent experiments.
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Figure 5 Expression of Thy1 surface marker in the testis and embryonic –like
stem cells by RT-PCR. (A) Representative RT-PCR gel image for the loading
control β-actin (460 bp) and Thy1 (166 bp). (B) Bar chart representing normalized
expression of Thy1 in relative to loading control. Positive control is collected from
spleen. Data is collected from three independent experiments.

Another embryonic stem cells marker is ESG1 (also known as DPPA). They
are a marker for early embryonic stem cells. Figure 6 reveal the expression of ESG1,
which is 2 folds higher in embryonic-like stem cells than cells collected from the
testis.
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Figure 6 Expression of ESG1 surface marker in the testis and embryonic –like
stem cells by RT-PCR. (A) Representative RT-PCR gel image for the loading
control β-actin (460 bp) and ESG1 (376 bp). (B) Bar chart representing normalized
expression of ESG1 in relative to loading control. Positive control is collected from
lung. Data is collected from three independent experiments.

For further molecular analysis, cripto TDGF1 was tested; it is a gene, which
encodes a growth factor, which is related to epidermal growth factor. It has a role in
embryogenesis and is a marker for embryonic stem cells. As shown in figure 7
expression of cripto TDGF1 is higher in embryonic-like stem cells than cells collected
from the testis.
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Figure 7 Expression of cripto TDGF1 surface marker in the testis and embryonic
–like stem cells by RT-PCR. (A) Representative RT-PCR gel image for the loading
control β-actin (460 bp) and cripto TDGF1 (174 bp). (B) Bar chart representing
normalized expression of cripto TDGF1 in relative to loading control. Positive control
is collected from spleen. Data is collected from three independent experiments.

3.5. Immunophenotyping by Flow Cytometer
Immunophenotyping was performed on testicular cells isolated from mice
testes at day 1 and embryonic-like stem cells at day 14. CD antigens are surface
proteins, which belong to different classes as glycoproteins, receptors and integrin;
different cell types have different antigens. Antibodies can be used to recognize CD
antigens on the surface of the cells and are used as a tool in cell sorting and cell
identifying. In our study the markers used in the FACS analysis were CD 90(Thy1),
CD 15 (SSEA-1), CD117 (c-kit), CD133, and SOX2; most of them are markers
present on the surface of embryonic stem cells. As shown in table 3 there is a
significant increase in the count of cells with the embryonic stem cells markers. There
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was an increase by ≈ 1.7 folds in CD 90 (Thy1), there was a higher increase in CD 15
(SSEA-1) marker by ≈ 8.2 folds, CD 117 (c-kit) by ≈ 6.18 folds, CD 133 by ≈ 5.14
folds, and finally SOX2 with an increase of ≈ 2.9 folds. When comparing results as
shown in figure 3 there is a significant increase in all embryonic stem cells markers,
which shows that germ cells are dedifferentiated to be embryonic-like stem cells
expressing the markers listed below. Figure 3 shows the significant increase in the
count of embryonic stem cells marker from day 1 to day 14.
Table 3 Count means of each CD surface marker used in Immunophenotyping of
cells from the testis and embryonic-like stem cells. Data presented as percentage
means of day 1 and day 14 ±SD of three independent experiments.

	
  

Surface Marker

Count on day 1

Count on day 14

CD 90(Thy1)

2,068±1,272

3,665±4,282

CD 15 (SSEA-1)

2,863±1,787

23,569±26,596

CD117 (c-kit)

2,669±1,666

16,518±18,795

CD133

4,745±2,691

24,404±27,424

SOX2

3,324±2,723

9,746±10,573
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Figure 8 Immunophenotyping of cell from the testis and embryonic-like stem
cells. Bar charts representing counts of cells bound to embryonic stem cells markers
at day 1 and day 14. Data are presented as ±SD of three independent experiments.
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A	
  

B	
  

Figure 9 Immunophenotyping of germ cells and embryonic-like stem cells.
Flowcytomeric analysis with FITC CD 90, FITC CD 15, PE CD117, PE CD133, and
PE SOX2. Row A represent germ cells at day 1 with different markers, row B is
embryonic-like stem cells at day 14 with different markers.
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4. Discussion
Embryonic stem cells is considered to be the most promising source for cell based
therapy in the field of regenerative medicine, these cells can give rise to all three germ
layers. Nevertheless, embryonic stem cells have some drawbacks; one of them is the
ethical and legal controversy that is associated with their collection. In order to avoid
such problem, generation of induced pluripotent stem cells from somatic cells through
various techniques has been well established. These techniques are such as somatic
cell nuclear transfer or directly reprogramming the cells by introducing embryonic
stem cells genes. Although these techniques have been well studied and offer a great
potential use in the field of regenerative medicine, yet, they do have some
complications. For instances, by examining the developed embryos from the nuclear
transfer technique, the embryonic stem cells were found to carry both genetic
information from both; the somatic cell and the new embryo. (Beyhan et al., 2007;
Fan et al., 2011; French et al., 2008; Tachibana et al., 2013; Yang et al., 2007).

Induced pluripotent stem cells was introduced by Shinya Yamanaka and his team
in 2006, the developed induced pluripotent stem cells by introducing 4 factors: Klf4,
Oct4, Sox2 and c-myc to mouse somatic cells. They have performed the same
technique using somatic human cells instead in the year 2008, and they have
succeeded in generating induced pluripotent stem cells from them too. A number of
scientists have performed the same technique using different somatic cell types and
different systems. However, these genes were introduced by viral vectors, this raised a
question of the safety of this technique. The fact of adding these genes, as some of
them are cancer causing, along with the fact that the viral vector might integrate to the
host genome, made these cells precluded from being used in regenerative medicine. A
number of researches have been dedicated to overcome the use of cancer causing
genes and viral vectors in order to be able to generate iPS cells to use these cells
safely for patients (Okita et al., 2007; Park et al., 2008; Takahashi & Yamanaka,
2006; Yu et al., 2007).
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Another technique that has been used is using cells isolated from the testis
to be reprogrammed to embryonic like stem cells. The ability of reprograming of
adult mouse germ cells into pluripotent stem cells has a great potential to be used
an animal model so it can be used later on in reprogramming human testis that can
be used in the field of regenerative medicine. Although cells collected from the
adult testis are unipotent and their differentiation is restricted to gametes
generation under normal conditions, it was found that when these cells are placed
in certain culture conditions they have the ability to give rise to cells that are
pluripotent (Guan et al., 2006; Kanatsu-Shinohara et al., 2004; Matsui et al.,
1992; Sabine et al., 2008). Different techniques have been reported using cells
isolated from the testis to generate pluripotent stem cells, it was reported that
primordial germ cells could give rise to embryonic like stem cells when cultured
in appropriate conditions. These embryonic like stem cells were reported to have
similar properties to embryonic stem cells that are isolated from the inner cell
mass (Resnick et al.,1992; Turnpenny et al.,2004).

We have isolated cells from adult mice testis; the total number of mice
used was 15 mice. Enzymatic and mechanical dispersion was done in order to end
with single cell culture, devoid from interstitial components (Bellve et al., 1977;
Dym et al., 1995). After the isolation step, cells from the testis we recultured in
defined culture media, which is designed for the culture of mouse embryonic stem
cells (Golestaneh et al., 2009; Guan et al., 2006; Kanatsu et al., 2004; Kubota
et al., 2006; Matsio et al., 1992). Some protocols use feeder layers to maintain
the growth of embryonic stem cells such as mouse embryonic fibroblast, these
feeder layers permit the continuous growth in an undifferentiated state (Amit el
at., 2003; Kanatsu-Shinohara et al., 2007). Other culture systems for embryonic
stem cells have been established without the use of feeder cells, the advantage of
not using feeder cells is to reduce exposing the embryonic stem cells to animal
pathogens. Furthermore, growing embryonic stem cells without feeder cells give a
safer yield to be used for future clinical application (Amit et al., 2004; Hong-mei
et al., 2006; Levenstein et al., 2006; Ludwig et al., 2006). In our study we have
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grown our embryonic-like stem cells without feeder cells, however we have
prepared our six well culture plates coated with gelatin to help cells to adhere.

After the enzymatic digestion of the testis we obtained a mixture of
somatic and germ cells, this is shown in figure 1. Our results at day 1 which is
shown in figure 1 shows a mixture of single cell suspension with cells of different
sizes and shapes including spermatozoa, spermatids and sertoli cells. Cells at day
1 grew separate from each other without forming colonies. As shown in Figure 1
cells have round nucleus with very small cytoplasm. In our protocol we did not
separate spermatogonial stem cells from the testis or any other germ cells before
the dedifferentiation process, as we have grown the whole mixture for
dedifferentiation. Other protocols pre-select spermatogonial cells with magnetic
activated cell separation (MACS); these cells are selected using markers such as
CD49f, CD90, or GDNFR-a1. The selection step is performed before the addition
of the designed culture media for the dedifferentiation step (Kabouta et al., 2004;
Shinohara et al., 1999; Stukenborg et al., 2007). Our results showed
comparable results than that with the pre-selection before the culture of the cells,
(Meng et al., 2000; Shamblott et al., 1998; Shamblott et al., 2001; Costoya et
al., 2004). Some protocols use collagen and laminin coat for the wells in order to
select spermatogonial cells pre-dedifferentiation step, this is done to end with a
highly pure spermatogonial cells (Hamra et al., 2004). As shown in figure 2
colonies of cells started to be formed from day 7, cells at day 7 started to be larger
in size with a big dark nucleus and small cytoplasm. Cells kept on forming
colonies from day 7 up to day 38, however the optimum time for the growth of the
embryonic-like stem cells were between day 7-21. Our results were comparable to
the results of Golestaneh, however their results showed colonies formation up to
day 60 (Golestaneh et al., 2009).

Molecular analysis of the isolated cells from the testis showed that these
cells changed their characteristics, loosing their germ cells properties and acquired
embryonic stem cells characteristics on the morphology level along with their
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expression pattern. These cells started to act more like embryonic stem cells
starting from day 7, losing their germ cells properties (Brinster et al., 1994; De
Rooij et al., 2006;Ginis et al., 2004; Meissner et al., 2007; Wernig et al., 2007).
At day 1-isolated cells showed the expression of VASA; which is a germ cell
marker. As shown in figure 3 VASA was expressed at day 1, however starting
from day 7 till day 14 these cells did not express VASA.

Isolated cells from day 1 were tested for the expression of embryonic stem
cells markers such as Nanog, Thy1, ESG1, and cripto TDGF1. As shown in figure
4 Nanog was not expressed at day 1, however their expression started at day 7 and
at day 14. Comparable results showed the discrete expression of VASA at day 1
and the expression of NANOG only after day 7 (Golestaneh et al., 2009; Okita
et al., 2007; Parker et al., 2008; Yu et al., 2007; Zaho et al., 2012). Nanog is
considered one of the key transcription factors, which have a role in maintaining
pluripotency along with self-renewal. Nanog was one of the transcription factors
used by Yamanaka to induce pluripotency to somatic cells, and was proven to
have a role in maintaining stemness (Chambers et al., 2003; Hatano et al., 2005;
Mitsui et al., 2003). Our results showed that Nanog is strictly expressed in
embryonic stem cells and not in germ cells. However other results showed high
expression of Nanog in primordial germ cells of E11.5 and E12.5 (Yamaguchi et
al., 2005) and in juvenile mouse testis as observed in our laboratory. Another
embryonic stem cells marker that was used is Thy1; figure 5 shows that Thy1 is
expressed both at day 1 and day 14. This might be explained that Thy1 is
expressed also in different somatic cells and is a marker for hematopoietic stem
cells. The cultured cells at day 1 are a mixture of different types of cells including
hematopoietic stem cells. However the expression pattern increased slightly at day
14 than day 1 because the growth of embryonic-like stem cells than other cell
types because of the media present which is suitable for the growth of embryonic
stem cells (Draper et al., 2002; Xu et al., 2001).
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Moreover, other embryonic stem cells markers were studied such as
ESG1. ESG1 is considered one of the potential markers for embryonic stem cells,
however they are also expressed in primordial germ cells, which is present in the
mixture collected at day 1 (Tanaka et al., 2006; Western et al., 2005).
Expression of ESG1 was higher at day 14 than at day 1 as shown in figure 6.
Another embryonic stem cells marker that was used is cripto TDGF1; it does have
a critical role during embryogenesis. Our results showed in figure 7 that it is also
expressed both at day 1 and at day 14. This marker is also expressed in other
somatic cells such as cardiomyocytes and fibroblast cells (Lonardo et al., 2010).
These results reveal that the marker that was strictly expressed in cells of day 1
was VASA, as for the embryonic stem cells Nanog was solely expressed at day 7
and 14.

Beside molecular analysis, flow cytometer analysis was performed on the
cells at day 1 and day 14. Figure 9 shows the count of cells in relationship with
the used embryonic stem cells surface marker. Starting with CD90 which is
expressed both in embryonic stem cells and hematopoietic stem cells, the figure
show the expression of CD90 both at day 1 and at day 14 with a slight increase at
day 14. However, for CD15, cd117, and CD133 expression at day 14, they
increased significantly. Similar results showed the expression of these markers in
embryonic stem cells, and the minimal expression of these markers in some types
of somatic cells such as cells from the testis (Henderson et al., 2002; Sundberg
et al., 2009). Last, SOX2; which is one of the key markers for embryonic stem
cells, their expression increased by more than 2 folds from day 1 to day 14.
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5. Conclusion

In conclusion, testicular cells from adult mouse testis can be isolated and
cultured in certain designated culture media so that they can dedifferentiate to
embryonic-like stem cells. When these cells are maintained under embryonic stem
cells culture condition they start to form colonies of embryonic-like stem cells
both in morphology and in their molecular expression. Dedifferentiating germ
cells to pluripotent stem cells can be used later on with human cells in order to be
used in regenerative medicine in order to treat a wide range of diseases such as
Parkinson’s and other incurable diseases. Nevertheless, further investigation is
required in order to make sure these cells are safe to be used clinically. Moreover,
studying the morphology, genetic imprinting, genetic stability and gene
expression of these cells is important before being used in humans. Additionally,
more studies should be done to differentiate these cells into different germ
lineages. These studies will facilitate providing essential data for potential clinical
applications.
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